Table of Contents
Epilepsy Research and Treatment
Volume 2015, Article ID 675071, 10 pages
http://dx.doi.org/10.1155/2015/675071
Review Article

Bridging the Gap between Evidence and Practice for Adults with Medically Refractory Temporal Lobe Epilepsy: Is a Change in Funding Policy Needed to Stimulate a Shift in Practice?

1Division of Neurosurgery, University of Toronto, Toronto, ON, Canada
2Toronto Western Hospital, University Health Network, Toronto, ON, Canada M5T 2S8
3Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, ON, Canada L8P 1H1
4Division of Neurosurgery, King Saud University, Riyadh, Saudi Arabia
5Institute of Medical Sciences, University of Toronto, Toronto, ON, Canada
6Division of Fundamental Neurobiology, Toronto Western Research Institute, Toronto Western Hospital, Toronto, ON, Canada M5T 2S8
7Krembil Neuroscience Center, Toronto, Canada

Received 17 October 2015; Accepted 11 November 2015

Academic Editor: József Janszky

Copyright © 2015 Alireza Mansouri et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. H. Reynolds, “The ILAE/IBE/WHO epilepsy global campaign history,” Epilepsia, vol. 43, supplement 6, pp. 9–11, 2002. View at Google Scholar · View at Scopus
  2. J. F. Tellez-Zenteno, M. Pondal-Sordo, S. Matijevic, and S. Wiebe, “National and regional prevalence of self-reported epilepsy in Canada,” Epilepsia, vol. 45, no. 12, pp. 1623–1629, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. S. S. Spencer, “When should temporal-lobe epilepsy be treated surgically?” Lancet Neurology, vol. 1, no. 6, pp. 375–382, 2002. View at Publisher · View at Google Scholar · View at Scopus
  4. S. S. Spencer, “Long-term outcome after epilepsy surgery,” Epilepsia, vol. 37, no. 9, pp. 807–813, 1996. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Wiebe, W. T. Blume, J. P. Girvin, and M. Eliasziw, “A randomized, controlled trial of surgery for temporal-lobe epilepsy,” The New England Journal of Medicine, vol. 345, no. 5, pp. 311–318, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Engel Jr., M. P. McDermott, S. Wiebe et al., “Early surgical therapy for drug-resistant temporal lobe epilepsy: a randomized trial,” The Journal of the American Medical Association, vol. 307, no. 9, pp. 922–930, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. P. de Flon, E. Kumlien, C. Reuterwall, and P. Mattsson, “Empirical evidence of underutilization of referrals for epilepsy surgery evaluation,” European Journal of Neurology, vol. 17, no. 4, pp. 619–625, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. G. Erba, L. Moja, E. Beghi, P. Messina, and E. Pupillo, “Barriers toward epilepsy surgery. A survey among practicing neurologists,” Epilepsia, vol. 53, no. 1, pp. 35–43, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. J. M. Bowen, O. C. Snead, K. Chandra, G. Blackhouse, and R. Goeree, “Epilepsy care in Ontario: an economic analysis of increasing access to epilepsy surgery,” Ontario Health Technology Assessment Series, vol. 12, no. 18, pp. 1–41, 2012. View at Google Scholar · View at Scopus
  10. M. E. Lim, J. M. Bowen, O. C. Snead et al., “Access to surgery for paediatric patients with medically refractory epilepsy: a systems analysis,” Epilepsy Research, vol. 107, no. 3, pp. 286–296, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. O. C. Cockerell, Y. M. Hart, J. W. A. S. Sander, and S. D. Shorvon, “The cost of epilepsy in the United Kingdom: an estimation based on the results of two population-based studies,” Epilepsy Research, vol. 18, no. 3, pp. 249–260, 1994. View at Publisher · View at Google Scholar · View at Scopus
  12. C. E. Begley, M. Famulari, J. F. Annegers et al., “The cost of epilepsy in the United States: an estimate from population-based clinical and survey data,” Epilepsia, vol. 41, no. 3, pp. 342–351, 2000. View at Publisher · View at Google Scholar · View at Scopus
  13. C. W. Bazil, “Comprehensive care of the epilepsy patient—control, comorbidity, and cost,” Epilepsia, vol. 45, supplement 6, pp. 3–12, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. D. Heaney, “Epilepsy at work: evaluating the cost of epilepsy in the workplace,” Epilepsia, vol. 40, supplement 8, pp. 44–47, 1999. View at Google Scholar · View at Scopus
  15. G. A. Baker, C. Camfield, P. Camfield et al., “Commission on outcome measurement in epilepsy, 1994–1997: final report,” Epilepsia, vol. 39, no. 2, pp. 213–231, 1998. View at Publisher · View at Google Scholar · View at Scopus
  16. C. E. Begley, D. R. Lairson, T. F. Reynolds, and S. Coan, “Early treatment cost in epilepsy and how it varies with seizure type and frequency,” Epilepsy Research, vol. 47, no. 3, pp. 205–215, 2001. View at Publisher · View at Google Scholar · View at Scopus
  17. “National institutes of health consensus conference. Surgery for epilepsy,” The Journal of the American Medical Association, vol. 264, no. 6, pp. 729–733, 1990. View at Publisher · View at Google Scholar
  18. S. G. Wiebe, A. Gafni, W. T. Blume, and J. P. Girvin, “An economic evaluation of surgery for temporal lobe epilepsy,” Journal of Epilepsy, vol. 8, no. 3, pp. 227–235, 1995. View at Publisher · View at Google Scholar · View at Scopus
  19. J. T. King Jr., M. R. Sperling, A. C. Justice, and M. J. O'Connor, “A cost-effectiveness analysis of anterior temporal lobectomy for intractable temporal lobe epilepsy,” Journal of Neurosurgery, vol. 87, no. 1, pp. 20–28, 1997. View at Publisher · View at Google Scholar · View at Scopus
  20. J. T. Langfitt, “Cost-effectiveness of anterotemporal lobectomy in medically intractable complex partial epilepsy,” Epilepsia, vol. 38, no. 2, pp. 154–163, 1997. View at Publisher · View at Google Scholar · View at Scopus
  21. C. E. Begley, J. F. Annegers, D. R. Lairson, T. F. Reynolds, and W. A. Hauser, “Cost of epilepsy in the United States: a model based on incidence and prognosis,” Epilepsia, vol. 35, no. 6, pp. 1230–1243, 1994. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Laupacis, D. Feeny, A. S. Detsky, and P. X. Tugwell, “How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations,” Canadian Medical Association Journal, vol. 146, no. 4, pp. 473–481, 1992. View at Google Scholar · View at Scopus
  23. M.-C. Picot, A. Jaussent, P. Kahane et al., “Medicoeconomic assessment of epilepsy surgery in adults with medically intractable partial epilepsy. Three-year outcomes from a multicenter French cohort,” Neurochirurgie, vol. 54, no. 3, pp. 484–495, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. M. B. Rao and K. Radhakrishnan, “Is epilepsy surgery possible in countries with limited resources?” Epilepsia, vol. 41, supplement 4, pp. S31–S34, 2000. View at Google Scholar · View at Scopus
  25. M. Platt and M. R. Sperling, “A comparison of surgical and medical costs for refractory epilepsy,” Epilepsia, vol. 43, supplement 4, pp. 25–31, 2002. View at Google Scholar · View at Scopus
  26. M.-C. Picot, D. Neveu, P. Kahane et al., “Cost-effectiveness of epilepsy surgery in a cohort of patients with medically intractable partial epilepsy—preliminary results,” Revue Neurologique, vol. 160, no. 5, pp. S354–S367, 2004. View at Google Scholar · View at Scopus
  27. J. Chen and D. Lei, “Surgery: a cost-effective option for drug-resistant epilepsy in China,” World Neurosurgery, vol. 82, no. 1-2, pp. E375–E376, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. W.-H. Hu, C. Zhang, K. Zhang, F.-G. Meng, N. Chen, and J.-G. Zhang, “Selective amygdalohippocampectomy versus anterior temporal lobectomy in the management of mesial temporal lobe epilepsy: a meta-analysis of comparative studies,” Journal of Neurosurgery, vol. 119, no. 5, pp. 1089–1097, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. C. B. Josephson, J. Dykeman, K. M. Fiest et al., “Systematic review and meta-analysis of standard vs selective temporal lobe epilepsy surgery,” Neurology, vol. 80, no. 18, pp. 1669–1676, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. P. Kwan, A. Arzimanoglou, A. T. Berg et al., “Definition of drug resistant epilepsy: consensus proposal by the ad hoc task force of the ILAE commission on therapeutic strategies,” Epilepsia, vol. 51, no. 6, pp. 1069–1077, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. I. E. Tureczek, J. Fandiño-Franky, and H.-G. Wieser, “Comparison of the epilepsy surgery programs in Cartagena, Colombia, and Zurich, Switzerland,” Epilepsia, vol. 41, supplement 4, pp. S35–S40, 2000. View at Publisher · View at Google Scholar · View at Scopus
  32. E. Widjaja, B. Li, C. D. Schinkel et al., “Cost-effectiveness of pediatric epilepsy surgery compared to medical treatment in children with intractable epilepsy,” Epilepsy Research, vol. 94, no. 1-2, pp. 61–68, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. Health Quality Ontario (HQO), Making Evidence Relevant, Ontario Health Technology Assessment Service, 2011, http://www.ontla.on.ca/library/repository/ser/255421/2011//2011no16dec.pdf.
  34. G. D. Cascino, M. R. Trenerry, E. L. So et al., “Routine EEG and temporal lobe epilepsy: relation to long-term EEG monitoring, quantitative MRI, and operative outcome,” Epilepsia, vol. 37, no. 7, pp. 651–656, 1996. View at Publisher · View at Google Scholar · View at Scopus
  35. V. Salanova, O. Markand, and R. Worth, “Temporal lobe epilepsy surgery: outcome, complications, and late mortality rate in 215 patients,” Epilepsia, vol. 43, no. 2, pp. 170–174, 2002. View at Publisher · View at Google Scholar · View at Scopus
  36. H. Choi, R. Carlino, G. Heiman, W. A. Hauser, and F. G. Gilliam, “Evaluation of duration of epilepsy prior to temporal lobe epilepsy surgery during the past two decades,” Epilepsy Research, vol. 86, no. 2-3, pp. 224–227, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. A. T. Berg, J. Langfitt, S. Shinnar et al., “How long does it take for partial epilepsy to become intractable?” Neurology, vol. 60, no. 2, pp. 186–190, 2003. View at Publisher · View at Google Scholar · View at Scopus
  38. C. Garcia Gracia, R. Yardi, M. W. Kattan et al., “Seizure freedom score: a new simple method to predict success of epilepsy surgery,” Epilepsia, vol. 56, no. 3, pp. 359–365, 2015. View at Publisher · View at Google Scholar
  39. A. S. Hakimi, M. V. Spanaki, L. A. Schuh, B. J. Smith, and L. Schultz, “A survey of neurologists' views on epilepsy surgery and medically refractory epilepsy,” Epilepsy and Behavior, vol. 13, no. 1, pp. 96–101, 2008. View at Publisher · View at Google Scholar · View at Scopus
  40. E. Kumlien and P. Mattsson, “Attitudes towards epilepsy surgery: a nationwide survey among Swedish neurologists,” Seizure, vol. 19, no. 4, pp. 253–255, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. Z. Haneef, J. Stern, S. Dewar, and J. Engel, “Referral pattern for epilepsy surgery after evidence-based recommendations: a retrospective study,” Neurology, vol. 75, no. 8, pp. 699–704, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. Epilepsy Implementation Task Force, Provincial Guidelines for the Management of Epilepsy in Adults and Children, Epilepsy Implementation Task Force, 2015, http://www.braininstitute.ca/sites/default/files/provincial_guidelines_for_the_management_of_epilepsy_is_adults_and_children_janurary_2015.pdf.
  43. M. W. Kellett, D. F. Smith, G. A. Baker, and D. W. Chadwick, “Quality of life after epilepsy surgery,” Journal of Neurology Neurosurgery and Psychiatry, vol. 63, no. 1, pp. 52–58, 1997. View at Publisher · View at Google Scholar · View at Scopus
  44. M. R. Sperling, “The consequences of uncontrolled epilepsy,” CNS Spectrums, vol. 9, no. 2, pp. 98–109, 2004. View at Google Scholar · View at Scopus
  45. J. T. Langfitt and S. Wiebe, “Early surgical treatment for epilepsy,” Current Opinion in Neurology, vol. 21, no. 2, pp. 179–183, 2008. View at Publisher · View at Google Scholar · View at Scopus
  46. O. Madore, “The Canada Health Act: overview and options,” 2005, http://www.parl.gc.ca/content/lop/researchpublications/944-e.htm.
  47. N. B. Fountain, P. C. Van Ness, R. Swain-Eng, S. Tonn, and C. T. Bever Jr., “Quality improvement in neurology: AAN epilepsy quality measures: report of the quality measurement and reporting subcommittee of the American Academy of Neurology,” Neurology, vol. 76, no. 1, pp. 94–99, 2011. View at Publisher · View at Google Scholar · View at Scopus
  48. R. A. Dudley and H. S. Luft, “Managed care in transition,” The New England Journal of Medicine, vol. 344, no. 14, pp. 1087–1092, 2001. View at Publisher · View at Google Scholar · View at Scopus
  49. J. E. Hurley, Health Economics, Edited by J. Sturrup, McGraw-Hill Ryerson, 2010.
  50. B. S. Frey, “On the relationship between intrinsic and extrinsic work motivation,” International Journal of Industrial Organization, vol. 15, no. 4, pp. 427–439, 1997. View at Publisher · View at Google Scholar · View at Scopus
  51. M. Kuhn, Quality in Primary Care: Economic Approaches to Analysing Quality-Related Physician Behavior, Office of Health Economics, London, UK, 2003.
  52. K. Grumbach, D. Osmond, K. Vranizan, D. Jaffe, and A. B. Bindman, “Primary care physicians' experience of financial incentives in managed-care systems,” The New England Journal of Medicine, vol. 339, no. 21, pp. 1516–1521, 1998. View at Publisher · View at Google Scholar · View at Scopus
  53. R. M. Andersen, “Revisiting the behavioral model and access to medical care: does it matter?” Journal of Health and Social Behavior, vol. 36, no. 1, pp. 1–10, 1995. View at Publisher · View at Google Scholar · View at Scopus
  54. G. Amundson, L. I. Solberg, M. Reed, E. M. Martini, and R. Carlson, “Paying for quality improvement: compliance with tobacco cessation guidelines,” Joint Commission Journal on Quality and Safety, vol. 29, no. 2, pp. 59–65, 2003. View at Google Scholar · View at Scopus
  55. M. Hoopmann, F. W. Schwartz, and J. Weber, “Effects of the German 1993 health reform law upon primary care practitioners' individual performance: results from an empirical study in sentinel practices,” Journal of Epidemiology and Community Health, vol. 49, supplement 1, pp. 33–36, 1995. View at Publisher · View at Google Scholar · View at Scopus
  56. P. Grootendorst, L. Goldsmith, J. Hurley, B. O'Brien, and L. Dolovich, “Financial incentives to dispense low-cost drugs: a case study of British Columbia pharmacare,” Working Paper 96-8, McMaster University Centre for Health Economics and Policy Analysis, 1996. View at Google Scholar
  57. R. A. Berenson and E. C. Rich, “US approaches to physician payment: the deconstruction of primary care,” Journal of General Internal Medicine, vol. 25, no. 6, pp. 613–618, 2010. View at Publisher · View at Google Scholar · View at Scopus
  58. J. Li, J. Hurley, P. Decicca, and G. Buckley, “PHYSICIAN response to pay-for-performance: evidence from a natural experiment,” Health Economics, vol. 23, no. 8, pp. 962–978, 2014. View at Publisher · View at Google Scholar · View at Scopus
  59. S. M. Campbell, D. Reeves, E. Kontopantelis, B. Sibbald, and M. Roland, “Effects of pay for performance on the quality of primary care in England,” The New England Journal of Medicine, vol. 361, no. 4, pp. 368–378, 2009. View at Publisher · View at Google Scholar · View at Scopus
  60. M. W. Friedberg, D. G. Safran, K. Coltin, M. Dresser, and E. C. Schneider, “Paying for performance in primary care: potential impact on practices and disparities,” Health Affairs, vol. 29, no. 5, pp. 926–932, 2010. View at Publisher · View at Google Scholar · View at Scopus
  61. A. M. Epstein, “Pay for performance at the tipping point,” The New England Journal of Medicine, vol. 356, no. 5, pp. 515–517, 2007. View at Publisher · View at Google Scholar · View at Scopus
  62. R. A. Dudley, A. Frolich, D. L. Robinowitz, J. A. Talavera, P. Broadhead, and H. S. Luft, Strategies To Support Quality-Based Purchasing: A Review of the Evidence, Agency for Healthcare Research and Quality, Rockville, Md, USA, 2004.
  63. T. F. Gavagan, H. Du, B. G. Saver et al., “Effect of financial incentives on improvement in medical quality indicators for primary care,” Journal of the American Board of Family Medicine, vol. 23, no. 5, pp. 622–631, 2010. View at Publisher · View at Google Scholar · View at Scopus
  64. Health Quality Ontario, “Epilepsy surgery: an evidence summary,” Ontario Health Technology Assessment Series, vol. 12, no. 1, pp. 1–28, 2012. View at Google Scholar
  65. R. Mayes and J. Walradt, “Pay-for-performance reimbursement in health care: chasing cost control and increased quality through ‘new and improved’ payment incentives,” Health Law Review, vol. 19, no. 2, pp. 39–43, 2011. View at Google Scholar
  66. R. E. Mechanic and S. H. Altman, “Payment reform options: episode payment is a good place to start,” Health Affairs, vol. 28, no. 2, pp. w262–w271, 2009. View at Publisher · View at Google Scholar · View at Scopus